Is AMTM or ULS more profitable?

UL Solutions has a net margin of 11.24% compared to Amentum's net margin of 1.04%. UL Solutions' return on equity of 30.99% beat Amentum's return on equity. Company Net Margins Return on Equity Return on Assets Amentum 1.04% 11.74% 4.78% UL Solutions 11.24% 30.99% 13.15%

Does the media favor AMTM or ULS?

In the previous week, UL Solutions had 4 more articles in the media than Amentum. MarketBeat recorded 6 mentions for UL Solutions and 2 mentions for Amentum. Amentum's average media sentiment score of 0.51 beat UL Solutions' score of 0.31 indicating that Amentum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amentum 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UL Solutions 2 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor AMTM or KSPI?

In the previous week, Joint Stock Company Kaspi.kz had 1 more articles in the media than Amentum. MarketBeat recorded 3 mentions for Joint Stock Company Kaspi.kz and 2 mentions for Amentum. Joint Stock Company Kaspi.kz's average media sentiment score of 0.93 beat Amentum's score of 0.51 indicating that Joint Stock Company Kaspi.kz is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amentum 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Joint Stock Company Kaspi.kz 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, AMTM or GRAB?

Grab has lower revenue, but higher earnings than Amentum. Amentum is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amentum $14.39B 0.36 $66M $0.60 35.06 Grab $3.37B 4.78 $268M $0.01 393.00

Is AMTM or GRAB more profitable?

Grab has a net margin of 10.67% compared to Amentum's net margin of 1.04%. Amentum's return on equity of 11.74% beat Grab's return on equity. Company Net Margins Return on Equity Return on Assets Amentum 1.04% 11.74% 4.78% Grab 10.67% 5.79% 3.28%

Does the media refer more to AMTM or GRAB?

In the previous week, Grab had 10 more articles in the media than Amentum. MarketBeat recorded 12 mentions for Grab and 2 mentions for Amentum. Amentum's average media sentiment score of 0.51 beat Grab's score of 0.43 indicating that Amentum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amentum 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Grab 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, MEDP or AMTM?

Medpace has higher earnings, but lower revenue than Amentum. Medpace is trading at a lower price-to-earnings ratio than Amentum, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.53B 6.08 $451.12M $15.91 33.83 Amentum $14.39B 0.36 $66M $0.60 35.06

Is MEDP or AMTM more profitable?

Medpace has a net margin of 17.19% compared to Amentum's net margin of 1.04%. Medpace's return on equity of 120.89% beat Amentum's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.19% 120.89% 24.79% Amentum 1.04% 11.74% 4.78%

Does the media refer more to MEDP or AMTM?

In the previous week, Medpace had 8 more articles in the media than Amentum. MarketBeat recorded 10 mentions for Medpace and 2 mentions for Amentum. Medpace's average media sentiment score of 0.55 beat Amentum's score of 0.51 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Amentum 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, AMTM or RTO?

Rentokil Initial has lower revenue, but higher earnings than Amentum. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amentum $14.39B 0.36 $66M $0.60 35.06 Rentokil Initial $6.91B 2.17 $470M N/A N/A

Does the media favor AMTM or RTO?

In the previous week, Amentum had 1 more articles in the media than Rentokil Initial. MarketBeat recorded 2 mentions for Amentum and 1 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.73 beat Amentum's score of 0.51 indicating that Rentokil Initial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amentum 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rentokil Initial 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Amentum (AMTM) Competitors

$21.03 -0.27 (-1.25%)

Closing price 07/10/2026 03:59 PM Eastern

Extended Trading

$21.22 +0.18 (+0.86%)

As of 07/10/2026 07:54 PM Eastern

Compare

AMTM vs. ULS, KSPI, GRAB, MEDP, and RTO

Should you buy Amentum stock or one of its competitors? MarketBeat compares Amentum with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Amentum include UL Solutions (ULS), Joint Stock Company Kaspi.kz (KSPI), Grab (GRAB), Medpace (MEDP), and Rentokil Initial (RTO). These companies are all part of the "business services" industry.

How does Amentum compare to UL Solutions?

Amentum (NYSE:AMTM) and UL Solutions (NYSE:ULS) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

Amentum presently has a consensus target price of $32.00, suggesting a potential upside of 52.13%. UL Solutions has a consensus target price of $101.54, suggesting a potential upside of 16.36%. Given Amentum's higher possible upside, research analysts clearly believe Amentum is more favorable than UL Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amentum	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
UL Solutions	0 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.45

39.9% of Amentum shares are owned by institutional investors. 19.4% of Amentum shares are owned by company insiders. Comparatively, 1.2% of UL Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, UL Solutions had 4 more articles in the media than Amentum. MarketBeat recorded 6 mentions for UL Solutions and 2 mentions for Amentum. Amentum's average media sentiment score of 0.51 beat UL Solutions' score of 0.31 indicating that Amentum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amentum	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
UL Solutions	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

UL Solutions has a net margin of 11.24% compared to Amentum's net margin of 1.04%. UL Solutions' return on equity of 30.99% beat Amentum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amentum	1.04%	11.74%	4.78%
UL Solutions	11.24%	30.99%	13.15%

Amentum has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, UL Solutions has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

UL Solutions has lower revenue, but higher earnings than Amentum. Amentum is trading at a lower price-to-earnings ratio than UL Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amentum	$14.39B	0.36	$66M	$0.60	35.06
UL Solutions	$3.05B	5.76	$325M	$1.71	51.03

Summary

UL Solutions beats Amentum on 10 of the 16 factors compared between the two stocks.

How does Amentum compare to Joint Stock Company Kaspi.kz?

Amentum (NYSE:AMTM) and Joint Stock Company Kaspi.kz (NASDAQ:KSPI) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations.

Joint Stock Company Kaspi.kz has a net margin of 24.89% compared to Amentum's net margin of 1.04%. Joint Stock Company Kaspi.kz's return on equity of 43.80% beat Amentum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amentum	1.04%	11.74%	4.78%
Joint Stock Company Kaspi.kz	24.89%	43.80%	10.03%

Joint Stock Company Kaspi.kz has lower revenue, but higher earnings than Amentum. Joint Stock Company Kaspi.kz is trading at a lower price-to-earnings ratio than Amentum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amentum	$14.39B	0.36	$66M	$0.60	35.06
Joint Stock Company Kaspi.kz	$7.70B	2.21	$2.04B	$10.84	8.27

Amentum has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market. Comparatively, Joint Stock Company Kaspi.kz has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

Amentum currently has a consensus target price of $32.00, indicating a potential upside of 52.13%. Joint Stock Company Kaspi.kz has a consensus target price of $96.67, indicating a potential upside of 7.80%. Given Amentum's higher possible upside, analysts plainly believe Amentum is more favorable than Joint Stock Company Kaspi.kz.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amentum	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Joint Stock Company Kaspi.kz	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.60

In the previous week, Joint Stock Company Kaspi.kz had 1 more articles in the media than Amentum. MarketBeat recorded 3 mentions for Joint Stock Company Kaspi.kz and 2 mentions for Amentum. Joint Stock Company Kaspi.kz's average media sentiment score of 0.93 beat Amentum's score of 0.51 indicating that Joint Stock Company Kaspi.kz is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amentum	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Joint Stock Company Kaspi.kz	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

39.9% of Amentum shares are owned by institutional investors. Comparatively, 32.2% of Joint Stock Company Kaspi.kz shares are owned by institutional investors. 19.4% of Amentum shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Joint Stock Company Kaspi.kz beats Amentum on 11 of the 17 factors compared between the two stocks.

How does Amentum compare to Grab?

Amentum (NYSE:AMTM) and Grab (NASDAQ:GRAB) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Grab has a net margin of 10.67% compared to Amentum's net margin of 1.04%. Amentum's return on equity of 11.74% beat Grab's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amentum	1.04%	11.74%	4.78%
Grab	10.67%	5.79%	3.28%

Amentum has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, Grab has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

Amentum presently has a consensus price target of $32.00, suggesting a potential upside of 52.13%. Grab has a consensus price target of $6.01, suggesting a potential upside of 52.81%. Given Grab's stronger consensus rating and higher possible upside, analysts plainly believe Grab is more favorable than Amentum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amentum	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Grab	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.91

Grab has lower revenue, but higher earnings than Amentum. Amentum is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amentum	$14.39B	0.36	$66M	$0.60	35.06
Grab	$3.37B	4.78	$268M	$0.01	393.00

In the previous week, Grab had 10 more articles in the media than Amentum. MarketBeat recorded 12 mentions for Grab and 2 mentions for Amentum. Amentum's average media sentiment score of 0.51 beat Grab's score of 0.43 indicating that Amentum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amentum	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Grab	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

39.9% of Amentum shares are held by institutional investors. Comparatively, 55.5% of Grab shares are held by institutional investors. 19.4% of Amentum shares are held by company insiders. Comparatively, 3.6% of Grab shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Grab beats Amentum on 11 of the 17 factors compared between the two stocks.

How does Amentum compare to Medpace?

Medpace (NASDAQ:MEDP) and Amentum (NYSE:AMTM) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

Medpace has a net margin of 17.19% compared to Amentum's net margin of 1.04%. Medpace's return on equity of 120.89% beat Amentum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.19%	120.89%	24.79%
Amentum	1.04%	11.74%	4.78%

78.0% of Medpace shares are owned by institutional investors. Comparatively, 39.9% of Amentum shares are owned by institutional investors. 20.5% of Medpace shares are owned by insiders. Comparatively, 19.4% of Amentum shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Medpace has higher earnings, but lower revenue than Amentum. Medpace is trading at a lower price-to-earnings ratio than Amentum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.08	$451.12M	$15.91	33.83
Amentum	$14.39B	0.36	$66M	$0.60	35.06

In the previous week, Medpace had 8 more articles in the media than Amentum. MarketBeat recorded 10 mentions for Medpace and 2 mentions for Amentum. Medpace's average media sentiment score of 0.55 beat Amentum's score of 0.51 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Amentum	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medpace currently has a consensus target price of $469.17, indicating a potential downside of 12.83%. Amentum has a consensus target price of $32.00, indicating a potential upside of 52.13%. Given Amentum's stronger consensus rating and higher probable upside, analysts clearly believe Amentum is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	1 Sell rating(s)	12 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.07
Amentum	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36

Medpace has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market. Comparatively, Amentum has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market.

Summary

Medpace beats Amentum on 11 of the 16 factors compared between the two stocks.

How does Amentum compare to Rentokil Initial?

Amentum (NYSE:AMTM) and Rentokil Initial (NYSE:RTO) are both business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

Amentum currently has a consensus target price of $32.00, suggesting a potential upside of 52.13%. Rentokil Initial has a consensus target price of $34.50, suggesting a potential upside of 16.30%. Given Amentum's higher probable upside, equities research analysts clearly believe Amentum is more favorable than Rentokil Initial.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amentum	1 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.36
Rentokil Initial	2 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.54

Rentokil Initial has lower revenue, but higher earnings than Amentum.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amentum	$14.39B	0.36	$66M	$0.60	35.06
Rentokil Initial	$6.91B	2.17	$470M	N/A	N/A

In the previous week, Amentum had 1 more articles in the media than Rentokil Initial. MarketBeat recorded 2 mentions for Amentum and 1 mentions for Rentokil Initial. Rentokil Initial's average media sentiment score of 1.73 beat Amentum's score of 0.51 indicating that Rentokil Initial is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amentum	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Rentokil Initial	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

39.9% of Amentum shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 19.4% of Amentum shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Amentum has a net margin of 1.04% compared to Rentokil Initial's net margin of 0.00%. Amentum's return on equity of 11.74% beat Rentokil Initial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amentum	1.04%	11.74%	4.78%
Rentokil Initial	N/A	N/A	N/A

Amentum has a beta of 0.35, indicating that its stock price is 65% less volatile than the broader market. Comparatively, Rentokil Initial has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

Summary

Amentum beats Rentokil Initial on 8 of the 15 factors compared between the two stocks.

Get Amentum News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMTM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMTM vs. The Competition

Export

Metric	Amentum	ENGINRG/R&D SVS Industry	Construction Sector	NYSE Exchange
Market Cap	$5.13B	$9.61B	$9.74B	$23.47B
Dividend Yield	N/A	1.90%	2.00%	4.02%
P/E Ratio	35.06	22.58	19.39	31.40
Price / Sales	0.36	1.88	27.37	20.35
Price / Cash	4.85	24.05	17.01	25.09
Price / Book	1.11	4.14	5.35	4.77
Net Income	$66M	$222.61M	$560.79M	$1.07B
7 Day Performance	-0.76%	-2.64%	-2.32%	-0.50%
1 Month Performance	-7.88%	-4.04%	-1.28%	0.06%
1 Year Performance	-11.17%	25.56%	6.52%	17.02%

Amentum Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMTM Amentum	4.3608 of 5 stars	$21.03 -1.2%	$32.00 +52.1%	-11.2%	$5.13B	$14.39B	35.06	50,000	News Coverage
ULS UL Solutions	3.9534 of 5 stars	$88.72 -8.5%	$101.54 +14.4%	+22.3%	$19.55B	$3.05B	51.32	14,851
KSPI Joint Stock Company Kaspi.kz	4.6701 of 5 stars	$90.19 +0.4%	$96.67 +7.2%	+10.1%	$17.07B	$7.70B	8.29	14,008	News Coverage
GRAB Grab	3.9361 of 5 stars	$3.85 -1.3%	$6.23 +61.8%	-21.4%	$15.98B	$3.37B	385.39	12,012	Analyst Forecast
MEDP Medpace	1.9458 of 5 stars	$565.09 +1.3%	$467.08 -17.3%	+66.4%	$15.92B	$2.53B	35.52	6,200	News Coverage Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AMTM) was last updated on 7/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Amentum (AMTM) Competitors

AMTM vs. ULS, KSPI, GRAB, MEDP, and RTO

How does Amentum compare to UL Solutions?

Summary

How does Amentum compare to Joint Stock Company Kaspi.kz?

Summary

How does Amentum compare to Grab?

Summary

How does Amentum compare to Medpace?

Summary

How does Amentum compare to Rentokil Initial?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMTM vs. The Competition

Amentum Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Amentum (AMTM) Competitors

AMTM vs. ULS, KSPI, GRAB, MEDP, and RTO

How does Amentum compare to UL Solutions?

Do analysts recommend AMTM or ULS?

Do institutionals & insiders hold more shares of AMTM or ULS?

Does the media favor AMTM or ULS?

Is AMTM or ULS more profitable?

Which has more risk & volatility, AMTM or ULS?

Which has preferable earnings and valuation, AMTM or ULS?

Summary

How does Amentum compare to Joint Stock Company Kaspi.kz?

Is AMTM or KSPI more profitable?

Which has stronger earnings and valuation, AMTM or KSPI?

Which has more risk and volatility, AMTM or KSPI?

Do analysts recommend AMTM or KSPI?

Does the media favor AMTM or KSPI?

Do institutionals and insiders believe in AMTM or KSPI?

Summary

How does Amentum compare to Grab?

Is AMTM or GRAB more profitable?

Which has more risk & volatility, AMTM or GRAB?

Do analysts recommend AMTM or GRAB?

Which has higher valuation & earnings, AMTM or GRAB?

Does the media refer more to AMTM or GRAB?

Do insiders & institutionals hold more shares of AMTM or GRAB?

Summary

How does Amentum compare to Medpace?

Is MEDP or AMTM more profitable?

Do institutionals and insiders hold more shares of MEDP or AMTM?

Which has stronger valuation & earnings, MEDP or AMTM?

Does the media refer more to MEDP or AMTM?

Do analysts rate MEDP or AMTM?

Which has more volatility and risk, MEDP or AMTM?

Summary

How does Amentum compare to Rentokil Initial?

Do analysts rate AMTM or RTO?

Which has preferable valuation & earnings, AMTM or RTO?

Does the media favor AMTM or RTO?

Do institutionals & insiders hold more shares of AMTM or RTO?

Is AMTM or RTO more profitable?

Which has more volatility & risk, AMTM or RTO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMTM vs. The Competition

Amentum Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools